Impact News +++ Blue Cap: Starke Unterbewertung nach dem Verkauf (4investors) +++ BLUE CAP Aktie +3,00%

ELANCO Aktie

>ELANCO Aktienkurs

16.296 EUR +5.9% (Tradegate)

Ask: 16.296 EUR / 370 Stück

Bid: 15.98 EUR / 380 Stück

Tagesumsatz: 162 Stück

Realtime Kurs von 8 bis 22 Uhr!

ELANCO Aktie über LYNX handeln

Intraday

1 Jahr

>ELANCO Performance

1 Woche: +1,2%

1 Monat: +22,7%

3 Monate: +38,4%

6 Monate: +42,1%

1 Jahr: +15,9%

laufendes Jahr: +32,8%

>ELANCO Aktie

Name:

ELANCO ANIMAL HEALTH.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US28414H1032 / A2N6BH

Symbol/ Ticker:

5EA (Frankfurt) / ELAN (NYSE)

Kürzel:

FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN

Index:

Webseite:

https://www.elanco.com/

Profil:

Elanco Animal Health Inc. is a pharmaceutical corp..
>Volltext..

Marktkapitalisierung:

7609.07 Mio. EUR

Unternehmenswert:

10725.41 Mio. EUR

Umsatz:

3860.36 Mio. EUR

EBITDA:

751.58 Mio. EUR

Nettogewinn:

373.64 Mio. EUR

Gewinn je Aktie:

0.76 EUR

Schulden:

3623.61 Mio. EUR

Liquide Mittel:

464.04 Mio. EUR

Operativer Cashflow:

492.45 Mio. EUR

Bargeldquote:

0.39

Umsatzwachstum:

-9.23%

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ELANCO

Letzte Datenerhebung:

27.08.25

>ELANCO Kennzahlen

Aktien/ Unternehmen:

Aktien: 496.81 Mio. St.

Frei handelbar: 99.06%

Leerverk. Aktien: 4.91%

Rückkaufquote: -

Mitarbeiter: 9450

Umsatz/Mitarb.: 0.4 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 6.4%

Bewertung:

KGV: 20.31

KGV lG: 19.8

KUV: 1.99

KBV: 1.3

PEG-Ratio: -

EV/EBITDA: 14.27

Rentabilität:

Bruttomarge: 42.98%

Gewinnmarge: 9.68%

Operative Marge: 4.66%

Managementeffizenz:

Gesamtkaprendite: 3.16%

Eigenkaprendite: 6.83%

>ELANCO Peer Group

Es sind 601 Aktien bekannt.

>ELANCO Chart & Kurs - NYSE

>ELANCO News

27.08.25 - 07:21	Elanco Animal Health set to join S&P MidCap 400, Sarepta to join S&P SmallCap 600 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

27.08.25 - 00:18	Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600 (PR Newswire)
	NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Inc. (NYSE: ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace Brookline Bancorp Inc. (NASD: BRKL) in the S&P SmallCap 600 effective prior to the opening of......

26.08.25 - 14:06	Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference (PR Newswire)
	GREENFIELD, Ind., Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 23rd Annual Global Healthcare Conference, September 8-9, 2025. Jeff Simmons, President and CEO, and Bob VanHimbergen, Executive Vice President and CFO, will......

15.08.25 - 21:06	Elanco CEO Jeff Simmons: Innovation and Sustainability Drive Long-Term Growth (Accesswire)
	NORTHAMPTON, MA / ACCESS Newswire / August 15, 2025 / Jeff Simmons, President and CEO of Elanco Animal Health, recently joined the Bloomberg Businessweek Daily to discuss the company's strategic fr......

08.08.25 - 02:00	Elanco raises 2025 innovation revenue outlook to $720M–$800M, signals margin expansion through new launches (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 22:06

Trump′s Team Impressed with Waller for Fed Chair | Bloomberg Businessweek Daily 8/7/2025 (Bloomberg)

On today's episode of Bloomberg Businessweek Daily, Carol Massar and Norah Mulinda look into Trump's latest calls for Intel's new CEO to resign. They also discussed Waller's emergence as favorite for Fed Chair among Trump's Team. Jeff Simmons, President and CEO of Elanco Animal Health also joined to discuss the company's quarterly earnings and the future of pet and animal health. (Source: Bloomberg)...

07.08.25 - 19:30	Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook (Benzinga)
	Elanco beats Q2 expectations and raises 2025 guidance as strong Pet Health sales and FX tailwinds offset tariff and investment impacts. read more...

07.08.25 - 15:15	Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates (Zacks)
	Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +30.00% and +4.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...

07.08.25 - 14:15	Elanco spikes after Q2 beat, guidance raise (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 13:48	Elanco (ELAN) Q2 Revenue Jumps 5% (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 13:24	Elanco Animal Health Raises 2025 Guidance (AFX)
	WASHINGTON (dpa-AFX) - Elanco Animal Health Incorporated (ELAN) said, for fiscal 2025, the company now expects adjusted earnings per share in $0.85 to $0.91, revised from prior guidance range of $......

07.08.25 - 12:33	Elanco Non-GAAP EPS of $0.26 beats by $0.06, revenue of $1.24B beats by $50M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 12:30	Elanco Animal Health Reports Second Quarter 2025 Results (PR Newswire)
	Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Second Quarter 2025 Financial Results: Revenue of $1,241 million, an increase of 5% year-over-year; 8% organic constant currency growth Reported Net Income of $11 million, Adjusted Net Income of......

24.07.25 - 23:45	Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs (PR Newswire)
	The European Commission's Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the world Launch to begin immediately with product in market before the end of Q3 2025 GREENFIELD, Ind., July 24, 2025 /PRNewswire/ -- Elanco Animal......

17.07.25 - 20:24	Leerink upgrades Elanco on pet health momentum, downgrades Zoetis (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

15.07.25 - 18:15	Are Options Traders Betting on a Big Move in ELAN Stock? (Zacks)
	Investors need to pay close attention to Elanco Animal Health Incorporated (ELAN) stock based on the movements in the options market lately....

10.07.25 - 14:03	Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement (PR Newswire)
	GREENFIELD, Ind., July 10, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2025 financial results on Thursday, August 7, 2025. Elanco will also conduct a conference call on that day with the investment community and media to provide......

09.07.25 - 18:42	Elanco gets US Agriculture department nod for TruCan (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.07.25 - 14:30	Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection (PR Newswire)
	TruCan Ultra CIV is the only ½ mL bivalent Canine Influenza Virus (CIV) vaccine offering broad protection against H3N2 and H3N8. 100% virus neutralization against 33 current field isolates.1 Unlike currently available products, only TruCan Ultra CIV demonstrates zero lung lesions in......

03.07.25 - 13:42	Elanco in licensing pact with Australia’s Neurizon (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wo es schon längere Zeit nicht gehagelt hat, läßt sich schon eine Hagelversicherung kaum verkaufen. - Komm.-Rat DDr. Norbert Zimmer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram